MC Dermott Center Inc.

MC Dermott Center Inc., doing business as Haymarket Center, is a Chicago-based tax-exempt nonprofit organization that operates as a federal grant recipient, delivering integrated behavioral health, substance use disorder treatment, and primary care services to vulnerable populations through grants from the Department of Health and Human Services, the Department of Housing and Urban Development, and the Bureau of Justice Assistance. The organization acts as prime recipient on 33 awards (34% of its footprint) and as sub-recipient on 64 awards (66%), with the vast majority of its federal activity flowing through state and local pass-through entities rather than direct federal contracting relationships.

Haymarket Center's capability portfolio centers on residential and outpatient treatment for substance use disorders, with integrated mental health and primary care delivery, supported employment programming, and harm-reduction services targeting populations experiencing homelessness, co-occurring mental illness, and infectious disease. Recent prime grant work includes a $525,000 five-year award from SAMHSA's Center for Substance Abuse Treatment (CFDA 93.490) beginning September 2026 to deliver comprehensive behavioral health and primary care to 119 pregnant and postpartum women with substance use disorders and their 48 children in residential treatment in Cook County; a $650,000 one-year award from HHS's Health Resources and Services Administration (CFDA 93.224) beginning August 2026 to expand primary health care access through the New Access Points Project, targeting 3,500 new patients experiencing homelessness and untreated medical and behavioral health conditions across 18 Chicago ZIP codes; and a $910,000 two-year grant from the Bureau of Justice Assistance (CFDA 16.753) beginning October 2024 to deliver mental health and trauma-focused training to 250 law enforcement officers and first responders in the Northeastern Illinois region. Additional significant recipient work includes a five-year SAMHSA grant for integrated care of individuals with substance use disorder and HIV, hepatitis C, or hepatitis B; a five-year supported employment program under SAMHSA's Center for Mental Health Services targeting 238 adults with mental health and substance use disorders; and a five-year grant for housing and treatment integration serving 300 homeless individuals with co-occurring substance use and mental disorders.

Customer concentration is highly specialized. The top five funding agencies account for 77% of awards by count, with the Department of Agriculture Food and Nutrition Service anchoring 33 awards (reflecting Haymarket's sub-recipient status under SNAP and related nutrition assistance programs administered by the Illinois Department of Human Services), followed by SAMHSA's Center for Substance Abuse Treatment (21 awards), HUD's Assistant Secretary for Community Planning and Development (11 awards), a second SAMHSA line (7 awards), and HHS's Health Resources and Services Administration (3 awards). The concentration reflects Haymarket's operational model: the vast majority of federal dollars flow to the organization through state agencies (primarily the Illinois Department of Human Services) and municipal grantees (the City of Chicago and Chicago Department of Public Health) rather than as direct federal awards. This sub-recipient posture exposes the organization to pass-through volatility and state budget cycles rather than direct federal recompete risk.

Haymarket operates exclusively through federal grant programs rather than federal contracts; the source documents no federal contract prime or sub-award activity. Activity has grown materially — from three awards in 2022 to 35 in 2024 — though recent trajectory appears to modulate, with 11 awards in 2025 and 6 awards year-to-date in 2026. Only four awards face ultimate completion within the next twenty-four months, limiting near-term recompete exposure, though the organization's heavy dependence on pass-through funding from state and local grantees creates structural recompete risk tied to state and municipal grant cycles rather than federal procurement timelines. Combined obligated funding across all awards is $56.4 million, with the most recent prime award (the pregnant and postpartum women residential treatment grant) arriving September 30, 2026.